Bowhead Specialty (NYSE:BOW – Get Free Report) announced its earnings results on Monday. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.47 by $0.01, FiscalAI reports. Bowhead Specialty had a net margin of 9.99% and a return on equity of 13.80%. The company had revenue of $163.86 million during the quarter, compared to the consensus estimate of $278.69 million.
Bowhead Specialty Trading Up 10.1%
NYSE:BOW opened at $33.68 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.47 and a quick ratio of 0.47. Bowhead Specialty has a 1 year low of $21.21 and a 1 year high of $35.07. The company has a market cap of $1.11 billion, a P/E ratio of 19.47, a P/E/G ratio of 0.92 and a beta of -0.11. The stock’s fifty day moving average price is $29.11 and its two-hundred day moving average price is $26.14.
Hedge Funds Weigh In On Bowhead Specialty
Hedge funds have recently bought and sold shares of the company. Raymond James Financial Inc. purchased a new stake in Bowhead Specialty in the 2nd quarter worth approximately $52,000. Tower Research Capital LLC TRC increased its holdings in shares of Bowhead Specialty by 99.0% in the second quarter. Tower Research Capital LLC TRC now owns 1,926 shares of the company’s stock worth $72,000 after purchasing an additional 958 shares during the period. Royal Bank of Canada increased its holdings in shares of Bowhead Specialty by 45.5% in the fourth quarter. Royal Bank of Canada now owns 2,065 shares of the company’s stock worth $59,000 after purchasing an additional 646 shares during the period. Quarry LP raised its position in shares of Bowhead Specialty by 19,489.5% in the third quarter. Quarry LP now owns 3,722 shares of the company’s stock worth $101,000 after buying an additional 3,703 shares in the last quarter. Finally, Quadrant Capital Group LLC raised its position in shares of Bowhead Specialty by 2,227.8% in the fourth quarter. Quadrant Capital Group LLC now owns 3,771 shares of the company’s stock worth $108,000 after buying an additional 3,609 shares in the last quarter.
More Bowhead Specialty News
- Positive Sentiment: American Family agreed to acquire Bowhead for $34.00 per share in cash, valuing the specialty insurer at approximately $1.2 billion. The transaction provides shareholders with a defined cash exit and appears to have driven the stock’s advance toward the offer price. American Family to buy Bowhead Specialty in $1.2 billion deal
- Positive Sentiment: Second-quarter earnings modestly exceeded expectations. Bowhead reported adjusted earnings of $0.48 per share, compared with the $0.47 consensus estimate and $0.37 a year earlier. The earnings beat helped reinforce investor interest alongside the acquisition announcement. Bowhead Specialty Q2 earnings top estimates
- Neutral Sentiment: The stock reached a new 12-month high following the earnings release and merger news. With the shares trading near the $34 cash offer, further upside may depend largely on deal completion rather than operating performance. Bowhead reaches new 12-month high
- Neutral Sentiment: Analysts collectively rate Bowhead Specialty “Hold,” suggesting limited expectations for additional gains after the acquisition announcement. The company also canceled its earnings conference call following disclosure of the merger agreement. Bowhead receives consensus Hold rating
- Negative Sentiment: Several law firms announced investigations into whether Bowhead’s directors obtained a fair price for shareholders in the American Family transaction. Although these announcements do not establish wrongdoing, they could create legal or closing uncertainty and may pressure the deal process. BOW stock alert investigation
Analyst Upgrades and Downgrades
BOW has been the topic of several recent analyst reports. Morgan Stanley lifted their target price on shares of Bowhead Specialty from $28.00 to $30.00 and gave the stock an “equal weight” rating in a research report on Monday, July 6th. Citizens Jmp cut their price objective on Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a research report on Monday, April 13th. Royal Bank Of Canada lowered Bowhead Specialty from an “outperform” rating to a “sector perform” rating and set a $34.00 target price for the company. in a research report on Tuesday. Weiss Ratings raised shares of Bowhead Specialty from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 23rd. Finally, UBS Group set a $28.00 price objective on shares of Bowhead Specialty in a report on Thursday, May 21st. Two research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, Bowhead Specialty has a consensus rating of “Hold” and a consensus price target of $33.00.
Get Our Latest Report on Bowhead Specialty
Bowhead Specialty Company Profile
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
See Also
- Five stocks we like better than Bowhead Specialty
- 3 Drone Stocks That Should Soar After the Summer Slump
- Tyson Foods Offers a Meaty Opportunity for Income Investors
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
